A comparison of different endoscopic modalities for the detection of dysplasia and early cancer in patients with Barrett's Oesophagus undergoing surveillance endoscopy.
Not Applicable
Recruiting
- Conditions
- Barrett's OesophagusOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCancer - Oesophageal (gullet)
- Registration Number
- ACTRN12613001190796
- Lead Sponsor
- A/Prof.Rajvinder Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 182
Inclusion Criteria
1. Patients aged 18-85 years undergoing surveillance endoscopy for Barrett's Oesophagus (BE) or whom are referred for further assessment of dysplasia/early cancer in BE
2. Patients with BE length of at least 0.5cm
These patients should also be on acid suppressive therapy (Proton pump inhibitor at a standard dose for minimum of 4 weeks to prevent inflammation from disrupting interpretation of BE tissue)
Exclusion Criteria
1. Inability or refusal to give informed consent
2. Patients with coagulation disorders
3. Patients with significant co morbidity, which includes severe heart failure, chronic renal disease, chronic obstructive airways disease
4. Patients who are pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method